Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review
Author(s) -
Ruth Casey,
Anne Y. Warren,
José-Ezequiel Martín,
Benjamin Challis,
Eleanor Rattenberry,
James Whitworth,
Katrina Andrews,
Thomas M. Roberts,
Graeme R. Clark,
Hannah D. West,
Philip Smith,
France Docquier,
Fay Rodger,
Vicki Rangitautehanga Murray,
Helen Simpson,
Yvonne Wallis,
Olivier Giger,
Maxine Tran,
Susan Tomkins,
Grant D. Stewart,
SooMi Park,
Emma R. Woodward,
Eamonn R. Maher
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-00562
Subject(s) - sdhb , paraganglioma , sdhd , pheochromocytoma , germline mutation , von hippel–lindau disease , medicine , renal cell carcinoma , pathology , disease , mutation , biology , genetics , gene
The co-occurrence of pheochromocytoma (PC) and renal tumors was linked to the inherited familial cancer syndrome von Hippel-Lindau (VHL) disease more than six decades ago. Subsequently, other shared genetic causes of predisposition to renal tumors and to PC, paraganglioma (PGL), or head and neck paraganglioma (HNPGL) have been described, but case series of non-VHL-related cases of renal tumor and pheochromocytoma/paraganglioma tumor association syndrome (RAPTAS) are rare.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom